Skip to main content
. 2019 Nov 14;25(42):6342–6353. doi: 10.3748/wjg.v25.i42.6342

Table 1.

Patient demographics

All patients H. pylori- positive H. pylori- negative P value Anticoagulants/antiplatelet drug/NSAIDs No drugs P value
Total 564 340 115 219 345
Male/female 343/221 223/117 66/49 0.111 127/92 216/129 0.271
Age (mean ± SD) 70.2 ± 14.3 66.6 ± 13.6 72.3 ± 14.3 < 0.012 77.1 ± 10.3 65.8 ± 14.7 < 0.012
H. pylori status
Positive 340 (60.3) - - 104 (47.5) 236 (68.4) < 0.011
Negative 115 (20.4) - - 56 (25.6) 59 (17.1)
Unknown 109 (19.3) - - 59 (26.9) 50 (14.5)
Toxic agents
Anticoagulants/antiplatelets/NSAIDs 219 (38.8) 104 (30.6) 56 (48.7) < 0.011 219 (100) 0
Anticoagulants 43 (7.6) 19 (5.6) 12 (10.4) 43 (19.6) 0
Antiplatelets 130 (23.0) 60 (17.6) 33 (28.7) 130 (59.4) 0
NSAIDs 174 (30.9) 85 (25.0) 39 (33.9) 174 (79.5) 0
Two or more drugs 76 (13.5) 50 (14.7) 26 (22.6) (50.7) 0
None 345 (61.2) 236 (69.4) 59 (51.3) 0 345 (100)
Single or multiple
Single 400 (70.9) 251 (73.8) 71 (61.7) 0.021 138 (63.0) 254 (73.6) 0.011
Multiple 108 (29.1) 89 (26.2) 44 (38.3) 81 (37.0) 91 (26.4)
Location (single ulcer)
U 127 (22.5) 80 (23.5) 15 (13.0) < 0.013 47 (21.5) 76 (22.0) 0.173
M 216 (38.3) 151 (44.4) 26 (22.6) 66 (30.1) 143 (41.4)
L 57 (10.1) 18 (5.3) 30 (26.1) 25 (11.4) 32 (9.3)
Forrest Classification 0.103 < 0.013
Ia 25 (4.4) 14 (4.1) 5 (4.3) 11 (5.0) 14 (4.1)
Ib 44 (7.8) 18 (5.3) 11 (9.6) 24 (11.0) 20 (5.8)
IIa 280 (49.6) 188 (55.3) 46 (40.0) 91 (41.6) 189 (54.8)
IIb 32 (5.7) 16 (4.7) 7 (6.1) 21 (9.6) 11 (3.2)
IIc 73 (12.9) 42 (12.4) 17 (14.8) 28 (12.8) 45 (13.0)
III 110 (19.5) 62 (18.2) 29 (25.2) 44 (20.1) 66 (19.1)
Previous antacids 86 (15.3) 35 (10.3) 28(24.4) < 0.011 41 (18.7) 46 (13.3) 0.631
PPIs 37 (6.6) 7 (2.1) 17(14.8) 18 (8.2) 19 (5.5)
H2 blockers 49 (8.7) 28 (8.2) 11 (9.6) 23 (10.5) 26 (7.5)
P-CAB 1 (0.2) 028 (8.2) 011 (9.6) 023 (10.5) 1 (0.3)
None 477 (84.6) 305 (89.7) 87 (75.7) 178 (81.3) 299 (86.7)
1

Fisher’s exact test.

2

Student’s t-test.

3

Pearson’s Chi-squared test. SD: Standard deviation; H. pylori: Helicobacter pylori; U: Upper; M: Middle; L: Lower; PPIs: Proton pump inhibitors; H2 blockers: Histamine type 2 receptor blockers; P-CAB: Potassium-competitive acid blocker; NSAIDs: Non-steroidal anti-inflammatory drugs.